Your browser doesn't support javascript.
loading
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Ilie, Silvia Mihaela; Briot, Nathalie; Constantin, Guillaume; Roussot, Nicolas; Ilie, Alis; Bergeron, Anthony; Arnould, Laurent; Beltjens, Françoise; Desmoulin, Isabelle; Mayeur, Didier; Kaderbhai, Courèche; Hennequin, Audrey; Jankowski, Clémentine; Padeano, Marie Martine; Costaz, Helène; Amet, Alix; Coutant, Charles; Coudert, Bruno; Bertaut, Aurélie; Ladoire, Sylvain.
Afiliación
  • Ilie SM; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, 1 Rue du Professeur Marion, 21000, Dijon, France.
  • Briot N; Unit of Methodology and Biostatistics, Georges Francois Leclerc Cancer Centre, Dijon, France.
  • Constantin G; Unit of Methodology and Biostatistics, Georges Francois Leclerc Cancer Centre, Dijon, France.
  • Roussot N; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, 1 Rue du Professeur Marion, 21000, Dijon, France.
  • Ilie A; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France.
  • Bergeron A; Department of Biology and Pathology of Tumors, Georges Francois Leclerc Cancer Centre, Dijon, France.
  • Arnould L; Department of Biology and Pathology of Tumors, Georges Francois Leclerc Cancer Centre, Dijon, France.
  • Beltjens F; Department of Biology and Pathology of Tumors, Georges Francois Leclerc Cancer Centre, Dijon, France.
  • Desmoulin I; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, 1 Rue du Professeur Marion, 21000, Dijon, France.
  • Mayeur D; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, 1 Rue du Professeur Marion, 21000, Dijon, France.
  • Kaderbhai C; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, 1 Rue du Professeur Marion, 21000, Dijon, France.
  • Hennequin A; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, 1 Rue du Professeur Marion, 21000, Dijon, France.
  • Jankowski C; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.
  • Padeano MM; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.
  • Costaz H; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.
  • Amet A; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.
  • Coutant C; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.
  • Coudert B; University of Burgundy-Franche Comté, 21000, Dijon, France.
  • Bertaut A; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, 1 Rue du Professeur Marion, 21000, Dijon, France.
  • Ladoire S; Unit of Methodology and Biostatistics, Georges Francois Leclerc Cancer Centre, Dijon, France.
Breast Cancer ; 30(6): 997-1007, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37561255
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Japón